Anavex Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Anavex Life Sciences

AVXL 3.685

-3.7%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: ImGettingBetter	5/12/2022 11:37:47 PM
	of 120

May 18 2022: Bitesize: Anavex Clinical Trial explained 11am May 18 2022: Bitesize: Anavex Clinical Trial explained The Anavex 2-73 UK clinical trial for adults with Rett Syndrome started at Manchester University and Kings’ College, London, in February 2021. Recruitment for the children’s trial, also taking place In Manchester and London, is now underway, with the trial due to start imminently. In this session, Dr Kaufmann from Anavex Life Sciences Corp. will speak about the science behind the trial and its design and Dr Banka from the University of Manchester will speak about the experiences and outcomes from the adult’s trial in Manchester. We will also hear from the parent of an adult who participated in the trial, plus Reverse Rett’s Andy Stevenson will speak about the role of Reverse Rett in recruitment and helping to make the experience as easy as possible for families. This session will take place via Zoom on Wednesday 18th May at 11am. reverserett.org.uk This should be really interesting hearing directly from the parent of an adult Rett participant. ------- Info came from Georgejj! at IHUB.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next